4O6E
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine Inhibitors of Erk2
4O6E の概要
エントリーDOI | 10.2210/pdb4o6e/pdb |
分子名称 | Mitogen-activated protein kinase 1, N-[(1S)-1-(3-chloro-4-fluorophenyl)-2-hydroxyethyl]-2-(tetrahydro-2H-pyran-4-ylamino)-5,8-dihydropyrido[3,4-d]pyrimidine-7(6H)-carboxamide (3 entities in total) |
機能のキーワード | protein kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
由来する生物種 | Homo sapiens (human) |
細胞内の位置 | Cytoplasm, cytoskeleton, spindle (By similarity): P28482 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 43096.85 |
構造登録者 | |
主引用文献 | Blake, J.F.,Gaudino, J.J.,De Meese, J.,Mohr, P.,Chicarelli, M.,Tian, H.,Garrey, R.,Thomas, A.,Siedem, C.S.,Welch, M.B.,Kolakowski, G.,Kaus, R.,Burkard, M.,Martinson, M.,Chen, H.,Dean, B.,Dudley, D.A.,Gould, S.E.,Pacheco, P.,Shahidi-Latham, S.,Wang, W.,West, K.,Yin, J.,Moffat, J.,Schwarz, J.B. Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2. Bioorg.Med.Chem.Lett., 24:2635-2639, 2014 Cited by PubMed Abstract: The discovery and optimization of a series of tetrahydropyridopyrimidine based extracellular signal-regulated kinase (Erks) inhibitors discovered via HTS and structure based drug design is reported. The compounds demonstrate potent and selective inhibition of Erk2 and knockdown of phospho-RSK levels in HepG2 cells and tumor xenografts. PubMed: 24813737DOI: 10.1016/j.bmcl.2014.04.068 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.95 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード